Literature DB >> 8402913

The human CD46 molecule is a receptor for measles virus (Edmonston strain).

R E Dörig1, A Marcil, A Chopra, C D Richardson.   

Abstract

Measles virus normally causes disease in human beings, and the host range of this virus may be determined by a specific receptor on the surface of primate cells. Human-rodent somatic cell hybrids were tested for their ability to bind measles virus, and only cells that contained human chromosome 1 were capable of binding virus. A study of lymphocyte markers suggested that the complement regulator known either as membrane cofactor protein or CD46 was the measles virus receptor. We proved this hypothesis by demonstrating that hamster cell lines that expressed human CD46 could subsequently bind virus. Furthermore, infected CD46+ cells produced syncytia and viral proteins. Finally, polyclonal antisera against CD46 inhibited virus binding and infection. These results prove that human CD46 permits cells both to bind measles virus and to support infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8402913     DOI: 10.1016/0092-8674(93)80071-l

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  407 in total

1.  Expression of envelope proteins of endogeneous C-type retrovirus on the surface of mouse and human oocytes at fertilization.

Authors:  B O Nilsson; M Jin; A C Andersson; P Sundström; E Larsson
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism.

Authors:  I C Johnston; V ter Meulen; J Schneider-Schaulies; S Schneider-Schaulies
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and vero cell-isolated measles viruses from the same patient.

Authors:  K Takeuchi; N Miyajima; F Kobune; M Tashiro
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

Review 4.  Virus receptors in the human central nervous system.

Authors:  B Schweighardt; W J Atwood
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

5.  Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity.

Authors:  Kaoru Takeuchi; Makoto Takeda; Naoko Miyajima; Fumio Kobune; Kiyoshi Tanabayashi; Masato Tashiro
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein.

Authors:  W P Duprex; S McQuaid; B Roscic-Mrkic; R Cattaneo; C McCallister; B K Rima
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.

Authors:  E C Hsu; R E Dörig; F Sarangi; A Marcil; C Iorio; C D Richardson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

8.  Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin.

Authors:  J P Langedijk; F J Daus; J T van Oirschot
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.

Authors:  Evanthia Galanis; Pamela J Atherton; Matthew J Maurer; Keith L Knutson; Sean C Dowdy; William A Cliby; Paul Haluska; Harry J Long; Ann Oberg; Ileana Aderca; Matthew S Block; Jamie Bakkum-Gamez; Mark J Federspiel; Stephen J Russell; Kimberly R Kalli; Gary Keeney; Kah Whye Peng; Lynn C Hartmann
Journal:  Cancer Res       Date:  2014-11-14       Impact factor: 12.701

10.  DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

Authors:  Katrin Friedrich; Jan Rh Hanauer; Steffen Prüfer; Robert C Münch; Iris Völker; Christodoulos Filippis; Christian Jost; Kay-Martin Hanschmann; Roberto Cattaneo; Kah-Whye Peng; Andreas Plückthun; Christian J Buchholz; Klaus Cichutek; Michael D Mühlebach
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.